Trials / Not Yet Recruiting
Not Yet RecruitingNCT07055568
A Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of Allogeneic iNKT Cell Infusion in Subjects With Advanced Pancreatic Cancer
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 18 (estimated)
- Sponsor
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the preliminary safety and tolerability of iNKT cell injection after infusion in each group of subjects, and to determine the maximum tolerated dose (MTD) and/or the recommended dose for extended studies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | iNKT | iNKT: Intravenous infusion, 0.5×10\^8cell-3.0×10\^8 cell |
Timeline
- Start date
- 2025-09-30
- Primary completion
- 2027-09-30
- Completion
- 2028-01-30
- First posted
- 2025-07-09
- Last updated
- 2025-07-09
Source: ClinicalTrials.gov record NCT07055568. Inclusion in this directory is not an endorsement.